Mandate

Vinge advises Ellevio

October 26, 2016

Vinge advises Ellevio on the acquisition of electricity network business in Nynäshamn (Nynäshamn Energi AB) from Kraftringen Energi. As a result, approximately 16,000 customers get a new network owner. The electricity network in Nynäshamn/Ösmo borders Ellevio’s regional network in Stockholm and further strengthens Ellevio’s already strong position in the Greater Stockholm area.

Ellevio is Sweden’s largest independent electricity network company with approximately 915,000 customers and 400 employees. Ellevio is owned by the Swedish Third National Pension Fund, Folksam, the Swedish First National Pension Fund and Borealis Infrastructure Management.

Closing of the transaction is subject to customary closing conditions. Closing is expected to take place no later than 30 November 2016.

Vinge’s team consisted primarily of responsible partner Johan Göthberg (Energy) together with associate Erik Claesson (M&A), partner Eva Fredriksson (IT), associate Matilda Persson (IT), Johan Cederblad (environment), Matilda Gustafsson (real estate), Sara Strandberg (employment) and Carolina Sandell (commercial agreements).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025